Last reviewed · How we verify
Amyotrophic lateral sclerosis
Approved treatments
- Radicava · Kk Bcj-94
Radicava works by scavenging free radicals and reducing oxidative stress in the body. - Qalsody · Biogen Ma
Qalsody works by binding to the messenger RNA (mRNA) of the Superoxide dismutase 1 (SOD1) gene, preventing its expression and reducing the production of the toxic SOD1 protein associated with ALS. - Rilutek · Covis
- Buphenyl · Amgen
- Radicava · Shanghai Auzone Biological Technology Co., Ltd.
- Relyvrio · Amylyx
Relyvrio works by inhibiting the enzyme phospholipase A2, which is involved in the breakdown of lipids in the brain.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Amyotrophic lateral sclerosis patent landscape — cliff calendar, originator estates, attackable patents
- Amyotrophic lateral sclerosis treatment landscape brief
- Amyotrophic lateral sclerosis treatment updates RSS
Frequently asked questions about Amyotrophic lateral sclerosis
What drugs treat Amyotrophic lateral sclerosis?
Tracked treatments include Radicava, Qalsody, Rilutek, Buphenyl, Relyvrio.
What is the treatment for Amyotrophic lateral sclerosis?
Standard treatment for Amyotrophic lateral sclerosis includes Radicava, Qalsody, Rilutek, Buphenyl, Relyvrio. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Amyotrophic lateral sclerosis patent cliff · Amyotrophic lateral sclerosis CI report
- Treatment: Radicava · Kk Bcj-94
- Treatment: Qalsody · Biogen Ma
- Treatment: Rilutek · Covis
- Treatment: Buphenyl · Amgen
- Treatment: Radicava · Shanghai Auzone Biological Technology Co., Ltd.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing